ABSTRACTMutations can increase the ceftazidimase activity of CTX-M-3 β-lactamase, as seen with its widespread variant CTX-M-15. This study compared the frequencies of emerging ceftazidime resistance in isogenic wild-type and hyper-mutable mutS CTX-M-3-producing Escherichia coli strains, and sequenced the mutant blaCTX-M alleles selected. Ceftazidime resistance emerged more readily in the hyper-mutable background than in the wild-type strain. All selected CTX-M mutants, in both the wild-type and the mutS derivatives, had single amino-acid changes at position 167, including a novel Pro167Gln substitution. These data emphasise the potential for further diversification of CTX-M enzymes
ABSTRACTCTX-M-type enzymes are a group of class A extended-spectrum β-lactamases (ESBLs) that are ra...
Our current understanding of how low antibiotic concentrations shape the evolution of contemporary β...
Reversal of antimicrobial resistance is an appealing and largely unexplored strategy in drug discove...
We report on a novel CTX-M extended-spectrum β-lactamase (ESBL), designated CTX-M-42, with enhanced ...
ABSTRACTTEM-1 and TEMpUC19 β-lactamases can gain activity against ceftazidime and other expandedspec...
International audienceABSTRACT A random mutagenesis technique was used to predict the evolutionary p...
The most common mechanism of resistance to β-lactam antibiotics in Gram-negative bacteria is the pro...
The natural diversification of CTX-M -lactamases led to the emergence of Asp240Gly variants in the c...
The CTX-M β-lactamases have emerged as the most widespread extended-spectrum β-lactamases (ESBLs) in...
CTX-M β-lactamases are widespread in Gram-negative bacterial pathogens and provide resistance to the...
MICs instead of resistance mechanisms, we aimed to investigate the ability of CTX-M-1 and CTX-M-14 t...
from hospitals in Rio de Janeiro (Brazil) were resistant to broad-spectrum cephalosporins and gave a...
Introduction: Difficult Gram-negative infections are increasingly treated with new β-lactamase inhib...
CTX-M β-lactamases are widespread in Gram-negative bacterial pathogens and provide resistance to the...
Paris, France, from a rectal swab of a hospitalized 5-month-old girl. These isolates had a clavulani...
ABSTRACTCTX-M-type enzymes are a group of class A extended-spectrum β-lactamases (ESBLs) that are ra...
Our current understanding of how low antibiotic concentrations shape the evolution of contemporary β...
Reversal of antimicrobial resistance is an appealing and largely unexplored strategy in drug discove...
We report on a novel CTX-M extended-spectrum β-lactamase (ESBL), designated CTX-M-42, with enhanced ...
ABSTRACTTEM-1 and TEMpUC19 β-lactamases can gain activity against ceftazidime and other expandedspec...
International audienceABSTRACT A random mutagenesis technique was used to predict the evolutionary p...
The most common mechanism of resistance to β-lactam antibiotics in Gram-negative bacteria is the pro...
The natural diversification of CTX-M -lactamases led to the emergence of Asp240Gly variants in the c...
The CTX-M β-lactamases have emerged as the most widespread extended-spectrum β-lactamases (ESBLs) in...
CTX-M β-lactamases are widespread in Gram-negative bacterial pathogens and provide resistance to the...
MICs instead of resistance mechanisms, we aimed to investigate the ability of CTX-M-1 and CTX-M-14 t...
from hospitals in Rio de Janeiro (Brazil) were resistant to broad-spectrum cephalosporins and gave a...
Introduction: Difficult Gram-negative infections are increasingly treated with new β-lactamase inhib...
CTX-M β-lactamases are widespread in Gram-negative bacterial pathogens and provide resistance to the...
Paris, France, from a rectal swab of a hospitalized 5-month-old girl. These isolates had a clavulani...
ABSTRACTCTX-M-type enzymes are a group of class A extended-spectrum β-lactamases (ESBLs) that are ra...
Our current understanding of how low antibiotic concentrations shape the evolution of contemporary β...
Reversal of antimicrobial resistance is an appealing and largely unexplored strategy in drug discove...